79 related articles for article (PubMed ID: 7987236)
1. [A myelopeptide, ameliorating the toxic effect of tumor cells on the functional activity of T-lymphocytes].
Strelkov LA; Mikhaĭlova AA; Fonina LA; Petrov RV
Dokl Akad Nauk; 1994 Sep; 338(1):125-6. PubMed ID: 7987236
[No Abstract] [Full Text] [Related]
2. [Immunoregulatory properties of myelopeptide-1].
Mikhaĭlova AA; Kirilina EA; Shanurin SIu; Fonina LA; Gur'ianov SA; Petrov RV
Dokl Akad Nauk; 1994 Aug; 337(4):553-4. PubMed ID: 7951040
[No Abstract] [Full Text] [Related]
3. Myelopeptides: bone marrow regulatory mediators.
Petrov RV; Mikhailova AA; Fonina LA
Biosci Rep; 1995 Feb; 15(1):1-14. PubMed ID: 7647288
[TBL] [Abstract][Full Text] [Related]
4. [A myelopeptide (bivalfor), possessing antitumor activity].
Strelkov LA; Mikhaĭlova AA; Fonina LA; Gur'ianov SA; Petrov RV
Biull Eksp Biol Med; 1995 May; 119(5):530-2. PubMed ID: 7579253
[No Abstract] [Full Text] [Related]
5. Myelopeptides: new immunoregulatory peptides.
Petrov R
Allergy Proc; 1995; 16(4):177-84. PubMed ID: 8566725
[TBL] [Abstract][Full Text] [Related]
6. [Myelopeptide-1 stimulates humoral immune response in irradiated mice].
Shanurin SIu
Radiats Biol Radioecol; 1994; 34(4-5):509-13. PubMed ID: 7951877
[TBL] [Abstract][Full Text] [Related]
7. [Myelopeptide MP-5 and fluorescent derivatives: synthesis and biological activity].
Fonina LA; Az'muko AA; Kalikhevich VN; Levit ML; Ardemasova ZA; Gur'ianov SA; Belevskaia RG; Efremov MA; Treshchalina EM; Mikhaĭlova AA
Bioorg Khim; 2008; 34(4):451-6. PubMed ID: 18695716
[TBL] [Abstract][Full Text] [Related]
8. [Myelopeptide-4--a new endogenous factor for differentiation of myeloid cells].
Strelkov LA; Mikhaĭlova AA; Gur'ianov SA; Efremov MA; Petrov RV
Dokl Akad Nauk; 1998 Jan; 358(1):134-6. PubMed ID: 9551320
[No Abstract] [Full Text] [Related]
9. Myelopeptide-2 induces the resistance of T-lymphocytes to tumor suppression.
Khabarov SV; Gerasimova GK; Mikhailova AA; Petrov RV
Dokl Biol Sci; 2003; 390():282-5. PubMed ID: 12940165
[No Abstract] [Full Text] [Related]
10. Myelopeptide-1 blocks the T-suppressor activity.
Petrov RV; Mikhailova AA; Kirilina EA
Folia Biol (Praha); 1994; 40(6):455-61. PubMed ID: 7589703
[TBL] [Abstract][Full Text] [Related]
11. [Endogenous immunoregulatory peptides (myelopeptides): structure, function, and mechanism of action].
Petrov RV; Mikhaĭlova AA; Fonina LA
Bioorg Khim; 1999 Nov; 25(11):811-5. PubMed ID: 10645485
[TBL] [Abstract][Full Text] [Related]
12. [A novel immunoregulating hexapeptide with antineoplastic effect].
Treshchalina EM; Sedakova LA; Vlasenkova NK; Zhukova OS; Firsova GA; Mikhaĭlova LM; Kolesnikova EIu; Zimakova NI; Khabarov SV; Gerasimova GK
Vopr Onkol; 2001; 47(3):321-7. PubMed ID: 11544832
[TBL] [Abstract][Full Text] [Related]
13. [Indoleamine 2, 3-dioxygenase activity in acute myeloid leukemia cells contributing to tumor immune escape].
Tang XQ; Zhao ZG; Wang HX; Li QB; Lü J; Zou P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Jun; 14(3):539-42. PubMed ID: 16800938
[TBL] [Abstract][Full Text] [Related]
14. [Myelopeptide-3--a bone marrow mediator, stimulating macrophage phagocytic activity].
Belevskaia RG; Mikhaĭlova AA; Fonina LA; Efremov MA; Petrov RV
Dokl Akad Nauk; 1998 Feb; 358(6):847-9. PubMed ID: 9541815
[No Abstract] [Full Text] [Related]
15. [The immunocorrective activity of myelopeptide-1 and myelopeptide-2 in cyclophosphane-treated mice].
Shanurin SIu; Belevskaia RG; Mikhaĭlova AA; Shanurin MIu
Eksp Klin Farmakol; 1995; 58(5):53-6. PubMed ID: 8704592
[No Abstract] [Full Text] [Related]
16. Functional roles of phenylalanine(7) of thymic humoral factor-gamma 2 in the impaired blastogenic response of uremic T-lymphocytes.
Abiko T; Sekino H
Drug Dev Ind Pharm; 1998 Jun; 24(6):569-72. PubMed ID: 9876625
[TBL] [Abstract][Full Text] [Related]
17. The quality and quantity of leukemia-derived dendritic cells from patients with acute myeloid leukemia and myelodysplastic syndrome are a predictive factor for the lytic potential of dendritic cells-primed leukemia-specific T cells.
Grabrucker C; Liepert A; Dreyig J; Kremser A; Kroell T; Freudenreich M; Schmid C; Schweiger C; Tischer J; Kolb HJ; Schmetzer H
J Immunother; 2010 Jun; 33(5):523-37. PubMed ID: 20463595
[TBL] [Abstract][Full Text] [Related]
18. [Myelopeptide correction of the differentiation of hematopoietic precursor cells in mice with experimental T-immunodeficiency].
Rudneva TB; Osipova EIu; Makhaĭlova AA; Man'ko VM
Biull Eksp Biol Med; 1989 Jun; 107(6):718-20. PubMed ID: 2790172
[TBL] [Abstract][Full Text] [Related]
19. In vitro infection of leukemic bone marrow with HTLV-I generates immortalized cell lines expressing T or myeloid cell phenotype.
Giuliani A; Vernole P; D'Atri S; Del Poeta G; D'Onofrio C; Faraoni I; Greiner JW; Bonmassar E; Graziani G
Leukemia; 1995 Dec; 9(12):2071-81. PubMed ID: 8609719
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow immunoregulatory peptides (myelopeptides): isolation, structure, and functional activity.
Petrov RV; Mikhailova AA; Fonina LA
Biopolymers; 1997; 43(2):139-46. PubMed ID: 9216250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
